BTAI Investors Should Contact Robbins LLP About Participating in the Class Action Against BioXcel Therapeutics
23. August 2023 15:17 ET
|
Robbins LLP
SAN DIEGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
BioXcel Therapeutics, Inc: Please contact the Portnoy Law Firm to recover your losses; September 5, 2023 deadline.
21. August 2023 15:56 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BioXcel Therapeutics, Inc....
BIOXCEL THERAPEUTICS, INC. INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies BTAI Investors of a Class Action Lawsuit and Upcoming Deadline
03. August 2023 09:00 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of persons and entities that purchased or acquired securities...
BioXcel Therapeutics, Inc. Investors: Contact Robbins LLP if You Incurred Significant Losses in BTAI
26. Juli 2023 07:46 ET
|
Robbins LLP
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
BioXcel Therapeutics, Inc: Please contact the Portnoy Law Firm to recover your losses; September 5, 2023 deadline
24. Juli 2023 17:53 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BioXcel Therapeutics, Inc....
BioXcel Therapeutics, Inc. (BTAI) Sued by Shareholders: BTAI Investors Should Contact Robbins LLP for Information About Their Rights
20. Juli 2023 14:53 ET
|
Robbins LLP
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
BioXcel Therapeutics, Inc. (BTAI) Investor Alert: Robbins LLP Reminds Investors of Class Action Against BioXcel Therapeutics, Inc.
13. Juli 2023 17:57 ET
|
Robbins LLP
SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
BioXcel Therapeutics, Inc: Please contact the Portnoy Law Firm to recover your losses; September 5, 2023 deadline
12. Juli 2023 17:48 ET
|
Portnoy Law
LOS ANGELES, July 12, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI). investors that a lawsuit filed on behalf of...
BioXcel Therapeutics. Investors: Please contact the Portnoy Law Firm to recover your losses
06. Juli 2023 15:26 ET
|
Portnoy Law
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BioXcel Therapeutics (NASDAQ: BTAI) investors that the law firm has initiated an investigation on behalf of investors that...